Vector Science & Therapeutics builds distributor network to expand peptide portfolio rollout in orthopedics, sports medicine

• Vector Science & Therapeutics outlined plans to build an independent distributor network to commercialize its investigational peptide portfolio in orthopedic, sports, regenerative channels.
• Rollout targets national coverage over time, with initial launches likely concentrated by region or clinical specialty to limit costs.
• Longer-term plan envisions up to 20 distributors supported by as many as 300 sub-representatives, scaling with sales growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vector Science and Therapeutics Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607210936PR_NEWS_USPR_____LA09014) on July 21, 2026, and is solely responsible for the information contained therein.